Research projects
Cima Universidad de Navarra
-
Non-Coding RNA and Regulation of the Cancer GenomeActive
Non-coding RNA and the regulation of cell division and genome stability
Cima Principal Investigator: Maite HuarteFunder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Solid TumorActive
POLIFARMA‐3D Hacia la personalización del tratamiento de infecciones respiratorias crónicas polimicrobianas: evaluación de fármacos sostenibles mediante modelos
Cima Principal Investigator: Carlos Ortiz de Solórzano Aurusa [SP]Funder: Gobierno de NavarraAward year 2022 -
Combination Strategies for Translational ImmunotherapyActive
Integration of 4-1BB (CD 137) agonists, interleukin-12, interleukin-18, and TGF-beta antagonists in synergistic combination strategies for cancer immunotherapy.
Cima Principal Investigator: Ignacio Melero BermejoFunder: Ministerio de Ciencia e InnovaciónAward year 2022 -
Active
SOCRATHeS: Development of innovative CAR-T Therapies for the Treatment of Hematological and Solid Tumors
Funder: Gobierno de NavarraAward year 2022 -
Regenerative MedicineActive
BIOHEART: Advanced bioengineering for developing cardiac tissue and its application to the study and detection of cardiotoxicity.
Cima Principal Investigator: Xabier Aranguren López [SP]Funder: Gobierno de NavarraAward year 2022 -
Translational OncologyActive
51-2021 Caloric restriction as a tool to enhance the efficacy and minimize the toxicity of immunotherapy for lung cancer.
Cima Principal Investigator: Daniel Ajona Martínez-PoloFunder: Gobierno de Navarra / Departamento de SaludAward year 2021 -
Oncogenes and Effector TargetsActive
PLEC2021-007959 MYCOMBIO. Use of MYC inhibition to overcome immunotherapy resistance in KRAS-driven NSCLC with diverse mutational profiles.
Cima Principal Investigator: Silvestre Vicent CambraFunder: Ministerio de Ciencia e InnovaciónAward year 2021 -
Translational OncologyActive
IDEAS211016AJON Short-term starvation to enhance antitumor activity and attenuate side effects of lung cancer immunotherapy side effects of immunotherapy for lung cancer.
Cima Principal Investigator: Daniel Ajona Martínez-PoloFunder: Asociación Española contra el CáncerAward year 2021 -
Regenerative MedicineActive
BIOGEN. Personalized bioengineering for the treatment of cardiovascular diseases. Study of the involvement of the GENder
Cima Principal Investigator: Olalla Iglesias GarcíaFunder: Gobierno de NavarraAward year 2021 -
Non-coding RNA in hepatocarcinoma and other liver diseasesActive
DATuM Development of microprotein-based antitumoural agents
Cima Principal Investigator: Mª Purificación Fortes Alonso [SP]Funder: Gobierno de NavarraAward year 2022